Get the Stockscreener App
0.68
2.86%
-0.02
Adagio Medical Holdings Inc stock is traded at $0.68, with a volume of 52,887.
It is down -2.86% in the last 24 hours and down -23.01% over the past month.
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
See More
Previous Close:
$0.70
Open:
$0.7004
24h Volume:
52,887
Relative Volume:
0.42
Market Cap:
$15.10M
Revenue:
$137.00K
Net Income/Loss:
$-24.37M
P/E Ratio:
-0.4575
EPS:
-1.4862
Net Cash Flow:
$-15.97M
1W Performance:
-11.92%
1M Performance:
-23.01%
6M Performance:
-27.66%
1Y Performance:
-37.04%
1-Day Range:
$0.68
$0.735
1-Week Range:
$0.68
$0.7999
52-Week Range:
$0.68
$2.582
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
Name
Adagio Medical Holdings Inc
Sector
Industry
Phone
(949) 348-1188
Address
26051 MERIT CIRCLE, LAGUNA HILLS
Compare ADGM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADGM
Adagio Medical Holdings Inc
|
0.68 | 15.10M | 137.00K | -24.37M | -15.97M | -1.4862 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adagio Medical Holdings Inc Stock (ADGM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Initiated | Piper Sandler | Overweight |
| Dec-02-25 | Initiated | Lake Street | Buy |
Adagio Medical Holdings Inc Stock (ADGM) Latest News
Adagio Medical Holdings Inc (ADGM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Adagio Medical Holdings Inc (ADGM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Adagio Medical Holdings Inc - TradingKey
Adagio Medical Holdings Inc (ADGM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Adagio Medical Holdings Inc (ADGM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adagio Medical Advances VT Cryoablation Study, Setting Up a New Cardiac Device Catalyst - TipRanks
Adagio Medical Receives IDE Approval to Investigate Next-Gen vCLAS Ventricular Ablation System - Medical Product Outsourcing
Adagio Medical Holdings, Inc. 8-K Filing: 2026 Annual Meeting Results & Company Details - Minichart
Adagio Medical Holdings elects directors and ratifies auditor at annual meeting - Investing.com Nigeria
Adagio Medical Shareholders Approve Directors and Auditor Ratification - TipRanks
Adagio Medical (NASDAQ: ADGM) posts 2026 director and auditor vote outcomes - Stock Titan
ADGM: Directors and auditor ratified with no shareholder questions; results to be filed on Form 8-K - TradingView
Adagio Medical Holdings Inc (ADGM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ADGM Q1 2026 Earnings: EPS Miss Amid Pre-Revenue Status; Stock Declines 3.5%ROE Trend Analysis - newsline.com
Adagio Medical receives Nasdaq notice for minimum bid price non-compliance - Investing.com Canada
Adagio Medical receives Nasdaq notice for minimum bid price non-compliance By Investing.com - Investing.com Australia
Adagio Medical Faces Nasdaq Minimum Bid Price Noncompliance - TipRanks
ADGM Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesSurprise Factor Analysis - newsline.com
Adagio Medical Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Adagio Medical (NASDAQ: ADGM) flagged by Nasdaq for sub-$1 bid price and faces delisting risk - Stock Titan
ADGM Q1 2026 Earnings: Wider Loss Misses Estimates as Pre-Revenue Stage ContinuesQuarterly Earnings Report - newsline.com
ADGM Q1 2026 Earnings: EPS Misses Estimates as Losses Widen; No Revenue YetEarnings Preview - newsline.com
Adagio Medical Holdings Inc (ADGM) Q1 2026 Earnings: EPS Miss Exacerbates Investor Concerns as Pre-Revenue Company Confronts Cash BurnProfit Guidance Range - newsline.com
Adagio Medical Holdings (ADGM) Dips 3.3% as Shares Test Key Support at $0.68New Listing Stocks - newsline.com
ADGM Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage ContinuesGuidance Accuracy Score - newsline.com
Lucid Capital Markets initiates Adagio Medical stock with buy rating - Investing.com UK
ADGM Initiates Coverage On LUCID CAPITAL MARKETS -- Rating Set t - GuruFocus
Number of shareholders of Adagio Medical Holdings, Inc – NASDAQ:ADGM - TradingView
Lucid Capital Markets initiates Adagio Medical stock with buy rating By Investing.com - Investing.com Canada
Adagio Medical Seeks FDA OK for Heart Device - Orange County Business Journal
ADGM Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue OperationsRevenue Inflection Point - newsline.com
Adagio Medical Holdings (ADGM) Holds Near Support After Marginal DeclineRounding Bottom - newsline.com
Adagio Medical Holdings (ADGM) Holds Steady Near $0.72 as Trading Volume Remains SubduedNews Sentiment - newsline.com
Adagio Medical’s vCLAS System Used to Treat Premature Ventricular Contractions - Medical Product Outsourcing
ADGM Q1 2026 Earnings: EPS Misses Estimates, Shares Slide 10.8%Revenue Inflection Point - newsline.com
ADGM - Finviz
Adagio Medical Holdings (ADGM) Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Development CostsProfitability Analysis - newsline.com
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - BioSpace
Adagio Files PMA for Breakthrough Ventricular Ablation System - TipRanks
Adagio Medical (ADGM) files FDA PMA for vCLAS ventricular tachycardia ablation system - Stock Titan
Adagio Medical submits FDA application for VT ablation system By Investing.com - Investing.com Nigeria
Adagio Medical submits FDA application for ventricular tachycardia ablation system - Medical Economics
Adagio Medical submits FDA application for VT ablation system - Investing.com
Adagio Medical submits premarket approval application to FDA for Vclas® ventricular ablation system - marketscreener.com
First purpose-built VT ablation system heads to FDA after 84% shock-free trial - Stock Titan
Adagio Medical Holdings' US$2.5m Market Cap Fall Books Insider Losses - Sahm
Perceptive Advisors (NASDAQ: ADGM) discloses 55.4% stake via Schedule 13G/A - Stock Titan
Adagio Medical Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
TradingKey - TradingKey
Adagio Medical : BofA Securities 2026 Health Care Conference Presentation (9e4df6) - marketscreener.com
Adage Capital (ADGM) reports 1,258,501 shares, 5.67% stake - Stock Titan
Adagio Medical Holdings Inc Stock (ADGM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):